Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 308 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia				Phase IV				GMALL02 NCT00198978
	German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)				Phase IV				GMALL01 NCT00198991
	Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab				Phase IV				GMALL03 NCT00199004
	Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults				Phase IV				GMALL05 NCT00199082
	LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive				Phase IV				LAL-Ph-2000 NCT00526305
	Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors				Phase IV				2006-00055-18 NCT00415103
	Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults				Phase IV				HEMOS ALL1105 NCT00797810
	Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer				Phase III, Phase II				RPCI-RP-9815 NCI-V99-1527, NCT00003816, RP 98-15
	Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)				Phase III, Phase II				Levosta-CBF-02/04 NCT00215007
	Stem Cell Transplantation for Hematological Malignancies				Phase III, Phase II				0005M52481 MT2000-12, NCT00176839


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute